Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Discover the Innovative Approach to Mental Health Treatment with Cybin ...
Cybin Inc: Paradigm Changing Ambitions (NYSE:CYBN) | Seeking Alpha
Cybin Announces First Patient Dosing in Psilocybin Depression Clinical ...
Cybin closes acquisition of Small Pharma | Cybin Inc posted on the ...
Cybin Stock: Optimism Quickly Fades (NYSE:CYBN) | Seeking Alpha
Cybin has partnered with Worldwide Clinical Trials — a global, full ...
Cybin enrolls in CYB003 study | Cybin Inc posted on the topic | LinkedIn
[Video] Cybin dosing in major depressive disorder study | Cybin Inc ...
Cybin (CYBN.NE) Completes 51st Pre-Clinical Psychedelic Molecule Study ...
Cybin plans to run four clinical trials in 2024 | Cybin Inc posted on ...
Cybin Outlines Upcoming Priorities and Milestones for its Clinical ...
Cybin Announces Groundbreaking Clinical Progress, Unveiling ...
Cybin Inc: The Psychedelic Revolution in Mental Health Treatment is ...
Cybin Raises $150M to Advance Psychedelic Therapy for Depression
Doug Drysdale | Cybin's Approach to Mental Health Innovation
Ethical Biopharmaceutical Company Cybin Establishes Presence in St ...
Cybin Announces Changes to Lead Buildout of Clinical Capabilities - AI ...
#cybin | Cybin Inc | 13 comments
Cybin R&D Day: Innovating New Treatment Approaches for Mental ...
Cybin to Participate in the Alliance Global Partners Healthcare Company ...
Cybin Announces Streamlined Clinical Alignment : r/shroomstocks
Cybin Receives FDA Breakthrough Therapy Designation for its Novel ...
Cybin Announces Publication in Frontiers in Psychology Journal ...
Cybin Announces Phase 2 Cohort 5 Dosing Completion of CYB003 in Major ...
Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical ...
Cybin Receives Australian Approval for Phase 3 EMBRACE Study of CYB003 ...
Cybin Announces Successful Completion of In Vivo Preclinical Studies ...
Cybin Applauds TheraPsil’s Advocacy to Bring Psilocybin Therapy to ...
EMBARK by Cybin
Generating the Data: Cybin Prepares for Phase 3 | $CYBN - YouTube
Cybin ($CYBN) Closes Acquisition of Phase 1 DMT Study; Accelerates ...
Cybin (CYBN.NEO) approved for first-in-human dosing - Equity.Guru
Cybin Scores Breakthrough Therapy Designation for Deuterated Psilocybin ...
What are the Porter's Five Forces of Cybin – CanvasBusinessModel.com
Cybin Inc. Accelerates Toward Psychedelic Therapy Commercialization ...
Cybin Corp Announces Partnership with the Toronto Centre for ...
Extremely proud of how the Cybin Inc. team has been able to leverage an ...
Cybin topline data from CYB003 study | Cybin Inc posted on the topic ...
Cybin reports positive data from Phase 1 studies of CYB004 and SPL028 ...
Cybin Therapeutics - LifeScienceHistory.com
Cybin Preps Its Psilocybin Analog for Clinical Trials - LA Weekly
QUARTERLY IN DEPTH INVESTMENT ANALYSIS UPDATE - CYBIN INC (NYSE: CYBN ...
The Cybin acquisition of Small Pharma creates a the leading player in ...
Join Cybin tomorrow at the 6th Annual Neuropsychiatric Drug Development ...
Cybin Inc (@cybininc) • Instagram photos and videos
Cybin Inc on LinkedIn: #changingminds #researchanddevelopment #cybin # ...
Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating ...
#cybin #mentalhealth #psychedelics #biotech #miglobal | Cybin Inc
Cybin | Tendril
Cybin Inc on LinkedIn: #researchanddevelopment #cybin # ...
Cybin Careers | Levels.fyi
Cybin Selects Anxiety Disorder Indications for Proprietary Psychedelic ...
Cybin reports positive results after CYB003 dose | Cybin Inc posted on ...
Cybin Finacial Analysis: Future Prospects are Uncertain | Psychedelic ...
Cybin and Fluence partner for CYB003 trial | Cybin Inc posted on the ...
PESTEL Analysis of Cybin Inc. (CYBN) – DCFmodeling.com
Cybin Partners with Kernel to Leverage its Breakthrough Neuroimaging ...
Cybin Moves Forward With Market Strategies for Expansion Into ...
Cybin predictions for 2025 – Quickapedia
Cybin administers psychedelic analogue to patients with major ...
Cybin Inc on LinkedIn: #psychedelictherapy #psychedelicresearch #cybin ...
Cybin reaches end of psilocybin analogue clinical trial for depression ...
Cybin Inc. Stock Overview — CYBN Summary & Analysis — Roic AI
Cybin Inc on LinkedIn: #cyb003 #mdd #cybin #fda #psychedelics # ...
Cybin Shares Positive Interim Topline Data for Deuterated Psilocybin ...
Why Cybin Thinks This Novel Psilocybin Analog Is the 'Superior Molecule'
Guggenheim Initiates Coverage of Cybin (CYBN) with Buy Recommendation
Cybin x Kernel | Tendril Design & Animation
Cybin (CYBN.NE) to target alcoholism in their CYB003 clinical studies ...
EXCLUSIVE INTERVIEW: Cybin - Transforming Mental Health Care - YouTube
Analysis: Cybin Shares Positive Interim Topline Data for Deuterated ...
Cybin interim phase 2 results could be leap in depression therapy
Cybin Inc on LinkedIn: #clinicaltrials #psychedelictherapy # ...
A Milestone Week for Cybin as Company Approaches Phase 3 for ...
Cybin reports positive Phase 2 data for CYB003 | Cybin Inc posted on ...
Cybin Leads in Aligning with FDA's New Psychedelic Drugs Guidelines: A ...
How Cybin Is 'Revolutionizing' Healthcare with Psychedelic Compounds
Cybin Advances Breakthrough Mental Health Treatments with Key 2026 ...
Cybin Announces Unprecedented Positive Interim Phase 2 Data for CYB003 ...
Cybin Rallies After Steve Cohen's Point 72 Disclosed 8.1% Equity ...
Buy Cybin Stock – CYBN Stock Quote Today & Investment Insights - Public.com
Cybin (CYBN) Analyst Rating Update: Canaccord Genuity Lowers PT
Cybin Inc. (CYBN) Launches Global Phase 3 Trial for Breakthrough ...
#cybin #gad | Cybin Inc
Cybin grants two U.S. patents for tryptamine-based drugs | Cybin Inc ...
Let's not forget about Cybin pipeline and the amazing team they have ...
The Top Companies Leading Psilocybin Research & Therapy
Losing Ones Sense of Self - How Psilocybin Breakthroughs Could Spark ...
I’m beyond excited to share that I’ve been selected as a Lead ...
#changingminds #researchanddevelopment #cybin #psychedelicresearch ...
#mentalhealth #cybin #mentalhealthresearch #psychedelictherapy # ...
Cybin: Upgrade To Hold - But Don't Get Too Carried Away (NYSE:CYBN ...
CybinInvestorsClub
#cybin #neuropsychiatry #breakthroughcompany #mentalhealthinnovation ...
Cybin's Psilocybin Program Granted FDA Breakthrough Designation
Cybin's Clinical Momentum and Strategic Alliances Position It for ...
Cybin’s Psilocybin Breakthrough | An Interview with CEO Doug Drysdale ...
Cybin: innovating the delivery of psychedelic therapy
Cybin: Business Model Canvas – CanvasBusinessModel.com
UK Approves Cybin's Phase 3 Depression Treatment Trial Across 60 Global ...
#changingminds #researchanddevelopment #cybin #psychedelicresearch # ...
Psychedelic treatment breakthrough: Cybin’s CYB003 gives hope to ...
Mastering the Vibin’ on the ‘Cybin Quest in Schedule 1 (Mushrooms)
Robert M. on LinkedIn: US FDA’s authorization of Cybin’s second IND is ...
Cybin’s Breakthrough Therapy for Major Depressive Disorder: A Game ...
Cybin: Researching Psychedelic Therapies for a Variety of Issues Using ...
#cybinaut #neuroscience2023 #innovationinhealthcare # ...
CYBN Stock Price and Chart — AMEX:CYBN — TradingView
CYB003 psilocybin analog earns FDA breakthrough status
#majordepressivedisorder #biotech #mentalhealthinnovation # ...
